Overall, our study uncovered an overlooked oncogenic mechanism involving eIF4E‐packaged EVs that upregulate cholesterol synthesis in macrophages, fostering immune suppression within the tumor microenvironment. The gene discussed is EIF4E; the disease is neoplasm.